Bredis Healthcare selected for Ministry of Science and ICT brain science R&D... to advance early Alzheimer’s diagnosis technology with ‘a drop of blood’
Summary
Bredis Healthcare was selected as the lead research institution for a government brain science R&D program. The company will work with academic and hospital partners to improve an ultra-sensitive blood-based platform for early Alzheimer’s diagnosis. It plans to develop the PLEX-STAR system and push its biomarker analysis technology closer to clinical use. The project supports the company’s broader strategy to commercialize high-sensitivity diagnostic solutions and expand its footprint in the blood-based dementia testing market.
Classifications
industries
HealthTech
applications
AI & Machine learning
AskAI Classifications
Labels
No AI classifications detected